Oral Vanadyl Sulfate Improves Hepatic And Peripheral Insulin Sensitivity In Patients With Non-insulin-dependent Diabetes Mellitus
Notes for this study:
||Non-randomized controlled trial
|Number of Subjects
6 persons with type II diabetes subject to Vanadium treatment for 3 weeks at 100mg daily improved glucose tolerance and insulin sensitivity in response to glucose by enhancing the actions of insulin; these persisted for 2 weeks after cessation of vanadium.
A trend to reduce triglycerides was noted, but failed to be significant.